引用次数
引用: 10,396
H-指数: 50
I10-指数 : 93
出版物: 166
Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
M. L. Shelanski , E. Castano , F. Prelli , B. Frangione
Laboratory Investigation 58 ( 4) 454 -458
227
1988
Primary ureteral amyloidosis
A. R. Rovegno , E. Castano , H. Fernandez , A. Avagnina
Archivos españoles de urología 51 ( 5) 485 -490
3
1998
Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease
A. Fernandez-Gamba , M. Leal , L. Morelli , E. Castano
Current Pharmaceutical Design 15 ( 31) 3644 -3655
81
2009
Amyloidosis of the central nervous system
Frangione B , Castaño Em , Ghiso Ja
Medicina-buenos Aires 47 ( 5) 534
1987
Apolipoprotein E and amyloidogenesis.
Castaño Em , Prelli Fc , Frangione B
Laboratory Investigation 73 ( 4) 457 -460
13
1995
Nicotinamide as potential biomarker for Alzheimer’s disease: a translational study based on metabolomics
Dalmasso Mc , Scherer M , Maier W , Ramirez A
2021
Alzheimer disease periventricular white matter lesions exhibit specific proteomic profile alterations
Eduardo M. Castao , Chera L. Maarouf , Terence Wu , Maria Celeste Leal
Neurochemistry International 62 ( 2) 145 -156
32
2013
Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L IMPLICATIONS FOR AMYLOIDOGENESIS AND ALZHEIMER'S DISEASE
Eduardo M. Castao , Frances Prelli , Mordechai Pras , Blas Frangione
Journal of Biological Chemistry 270 ( 29) 17610 -17615
56
1995
Cerebrospinal fluid inhibits Alzheimer β‐amyloid fibril formation in vitro
Thomas Wisniewski , Eduardo Castano , Jorge Ghiso , Blas Frangione
Annals of Neurology 34 ( 4) 631 -633
54
1993
Proteomic Analysis of Alzheimer’s Disease Cerebrospinal Fluid from Neuropathologically Diagnosed Subjects
Chera Maarouf , Tracy Andacht , Tyler Kokjohn , Eduardo Castano
Current Alzheimer Research 6 ( 4) 399 -406
40
2009
Differences between vascular and plaque core amyloid in Alzheimer's disease.
Frances Prelli , Eduardo Castano , George G. Glenner , Blas Frangione
Journal of Neurochemistry 51 ( 2) 648 -651
295
1988
Comparison of clinical and pathological phenotypes in two ethnically and geographically unrelated pedigrees segregating an equivalent presenilin 1 mutation.
Ricardo Jorge , Carlos Mangone , Eduardo Castano , Carlos Perandones
Journal of Neuropsychiatry and Clinical Neurosciences 12 ( 3) 359 -363
3
2000
Sustainable Environment Research
Irma Robles , Erika Bustos , János Lakatos
molecules 1 3 -3
2016
Proteínas Anormales en la Enfermedad de Alzheimer
Laura Morelli , Eduardo M Castaño
Ciencia hoy 7 ( 41) 32 -43
3
1997
Internalization and resistance to degradation of Alzheimer's Aβ1–42 at nanomolar concentrations in THP-1 human monocytic cell line
Laura Morelli , Guillermo H Giambartolomei , Maria I Prat , Eduardo M Castaño
Neuroscience Letters 262 ( 1) 5 -8
12
1999
Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease.
Pamela V Martino Adami , Celia Quijano , Natalia Magnani , Pablo Galeano
Journal of Cerebral Blood Flow and Metabolism 37 ( 1) 69 -84
35
2017
Immunoglobulin lambda light chains are the precursors of ureteral localized amyloidosis: a micromethod for extraction of amyloid
Eduardo M Castaño , Frances Prelli , Laura Morelli , Alejandra Avagnina
Amyloid 4 ( 4) 253 -258
15
1997
Detergent resistant membrane-associated IDE in brain tissue and cultured cells: Relevance to Aβ and insulin degradation
Ayelén Bulloj , María C Leal , Ezequiel I Surace , Xue Zhang
Molecular Neurodegeneration 3 ( 1) 22 -22
34
2008
Histopathological and molecular heterogeneity among individuals with dementia associated with Presenilin mutations
Chera L Maarouf , Ian D Daugs , Salvatore Spina , Ruben Vidal
Molecular Neurodegeneration 3 ( 1) 20 -20
46
2008
The biochemical aftermath of anti-amyloid immunotherapy.
Chera L Maarouf , Ian D Daugs , Tyler A Kokjohn , Walter M Kalback
Molecular Neurodegeneration 5 ( 1) 39 -39
35
2010